Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
EGFR-IN-7 is an inhibitor of wild-type and mutant EGFR (IC50s = 1.07, 0.46, 0.13, 0.26, and 0.19 nM for wild-type EGFR, EGFRd746-750/T790M/C797S, EGFRL858R/T790M/C797S, EGFRd746-750/T790M, and EGFRL858R/T790M, respectively).1 It inhibits the proliferation of wild-type EGFR-expressing A431, EGFRd746-750/T790M/C797S-expressing Ba/F3, EGFRd746-750/T790M/C797S-expressing H1975, and EGFRd746-750-expressing PC-9 cells (IC50s = 147, 26.8, 163, and 45 nM, respectively). EGFR-IN-7 reduces tumor growth in triple mutant EGFR mouse xenograft models.
WARNING This product is not for human or veterinary use.
1. Abstract 1320: Preclinical evaluation of TQB3804, a potent EGFR C797S inhibitor. Cancer Res. 79(13_Suppl), (2019).